Orthotopic bladder substitute in renal transplant recipients: Experience with Studer technique and literature review - Abstract

Department of Urology, University of Pisa, Pisa, Italy.

Division of Surgery in Uremic and Diabetic Patient, University of Pisa, Pisa, Italy.

 

 

Renal transplant recipients with high-risk bladder cancer following cystectomy need a urinary diversion preserving the renal function and possibly maintaining body image, while still offering the best oncological outcome. The aim of this report is to describe our experience of radical cystectomy and orthotopic ileal neobladder with Studer technique in this population, and to review the literature. We performed radical cystectomy and Studer ileal neobladder in four male patients (median age 67 years) after median time of 9.5 years following renal transplantation. Pathology revealed pT1HGN+ transitional cell carcinoma in one case, pT1HGN0 in two and pT3aHGN0 in one. Two patients presenting aggressive disease (N+ and pT3a) died of tumour progression after 20 and 14 months, respectively, while the other two are alive after 56 and 36 months of follow-up with no evidence of disease, stable serum creatinine (2.29 and 1.6 mg/dl) and mild metabolic acidosis. Day and night-time urinary continence were satisfactory in all patients. Good functional outcomes have been reported in the 20 cases of ileal orthotopic neobladder with different techniques published so far and the global experience of 24 cases with a median follow-up of 39 months documents a cancer specific survival of 62.5%.

Written by:
Manassero F, Di Paola G, Mogorovich A, Giannarini G, Boggi U, Selli C.   Are you the author?

Reference: Transpl Int. 2011 Sep;24(9):943-8.
doi: 10.1111/j.1432-2277.2011.01292.x

PubMed Abstract
PMID: 21722198

UroToday.com Bladder Cancer Section